Given below are breast cancer statistics for USA along with ethnicity prevalence and mortality rates. In the previos post we discussed these facts and figures worldwide
Breast cancer rates for U.S.A.
- Breast cancer is the second most common cancer among women in the United States.
- In 2007, 202,964 women were diagnosed with breast cancer.
- In the same year, 40598 women died from breast cancer.
- In 2010, 207,090 cases of invasive breast cancer were newly diagnosed.
- In the same year, 54,010 cases of breast cancer in situ (non invasive breast cancer) were diagnosed.
- Less than 1% of new cases are breast cancer in men.
- In 2010, 1,970 new cases of male breast cancer were diagnosed.
- In 2010, about 40,000 women died of breast cancer.
- In the seven years from 1999 to 2006, incidence of breast cancer decreased by 2% per year due to increased awareness, early detection from screening procedures and newer treatments. Credit can also be given to reduced use of hormonal replacement therapy after its connection with breast cancer was published.
- Breast cancer accounts for 28% of all cancers detected.
- Nearly one out four cancer patients in te United States is a breast cancer patient.
- It is the most common cancer in women after skin cancer.
- Breast cancer rates second after lung cancer to cause death in women due to cancer.
- In 2010, 2.5 million breast cancer surviving women existed in the United States.
- About 5 % to 10% of breast cancers are due to genetic reasons.
- About 80% of breast cancer patients have no family history of breast cancer.
- About 1 in 8 women in the United States (about 13%) will develop invasive breast cancer during her lifetime.
- In 2021, it is estimated that about 281,550 women in the U.S. will be diagnosed with invasive breast cancer and about 49,290 new cases of non-invasive (in situ) breast cancer.
- It is again estimated that about 2,650 men will diagnosed with invasive breast cancer in 2021.
- About 43,600 U.S. women are expected to succumb to breast cancer in 2021.
- The overall death rate from breast cancer has reduced by 1% per year during the period from 2013 to 2018. This is due to early detection due to screening procedures and advanced treatment options.
- In the U.S., more women die from breast cancer than from any other cancer except lung cancer.
- As of January 2021, the United States has had more than 3.8 million women diagnosed with breast cancer.
- The U.S. breast cancer incidence rates began to decline in the year 2000, after higher rates during previous two decades. This could be due to the reduced use of hormone replacement therapy (HRT) by women
- Less than 15% of women who develop breast cancer have an immediate family member diagnosed with it.
- About 85% of women with breast cancer no family history of breast cancer.
U.S. Breast cancer prevalence accdording to ethnicity
- In women below the age of 45 years, breast cancer is more common in Black women than White women. Generally, Black women are more likely to die of breast cancer.
- Asian, Hispanic, and Native-American women have a lower risk of developing and dying from breast cancer.
- Ashkenazi Jewish women have a higher risk of developing breast cancer because of a higher BRCA mutations.
- White women and African American women are more prone to developing and dying from breast cancer than Asian, Hispanic and Native American women.
- White women are more prone to develop breast cancer but less likely to die from it.
- African American women have more aggressive breast tumors for which no explanation is available.
Breast cancer mortality rates for U.S.A.
- More Black women die from breast cancer than White women.
- In the twenty years from 1970 to 1990, breast cancer mortality in U.S. increased by 0.3% in white women, while the rise was comparatively much more in black women –1.6%.
- In the decade following 1990, the mortality rate in white women declined by 2.5% and in black women the decrease was 1%.
- This decline in the US breast cancer mortality was probably due to early diagnosis, awareness and newer treatments.